INTERNATIONAL PATENT: SHANGHAI SKIN DISEASE HOSPITAL, 上海市皮肤病医院 FILES APPLICATION FOR "USE OF FORMONONETIN IN REDUCING IMIQUIMOD-INDUCED INFLAMMATORY CYTOKINE EXPRESSION BY MEANS OF INHIBITING INTERFERON SIGNALING PATHWAY"

GENEVA, March 8 -- SHANGHAI SKIN DISEASE HOSPITAL (No. 1278, Baode RoadJingan District, Shanghai 200443), 上海市皮肤病医院 (中国上海市静安区保德路1278号) filed a patent application (PCT/CN2023/131798) for "USE OF FORMONONETIN IN REDUCING IMIQUIMOD-INDUCED INFLAMMATORY CYTOKINE EXPRESSION BY MEANS OF INHIBITING INTERFERON SIGNALING PATHWAY" on Nov 15, 2023. With publication no. WO/2025/043894, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Propert...